he ta starch

2
Brand Name: Hextend ® GENERIC NAME: 6% Hetastarch in Lactated Electrolyte Injection MANUFACTURER: Biotime inc. DATE OF FDA APPROVAL: November 2013 DESCRIPTION: Hextend ® is a sterile medical IV solution used as a blood plasma volume expander to replace blood volume lost in routine surgery, emergency trauma surgery and other applications, a condition known as hypovolemia (low blood volume). Hextend’s unique formulation contains a modified form of starch (6% hetastarch) suspended in a balanced electrolyte solution. The product more closely mirrors the electrolyte balance of blood than other products that contain 6% hetastarch in simple salt (sodium chloride, or saline) solutions. Hextend is not a substitute for blood or plasma. CLASSIFICATION: Plasma expander MECHANISM OF ACTION: The body automatically detects the lower haemoglobin level, and compensatory mechanisms start up. The heart pumps more blood with each beat. Since the lost blood was replaced with a suitable fluid, the now diluted blood flows more easily, even in the small vessels. As a result of chemical changes, more oxygen is released to the tissues. These adaptations are so effective that if only half of the red blood cells remain, oxygen delivery may still be about 75 percent of normal. A patient at rest uses only 25 percent of the oxygen available in his blood. In extreme cases, patients have survived with a haemoglobin level of 2 g/dl, about 1/7 the norm, although levels this low are very dangerous. INDICATION: Hetastarch is used to treat or prevent hypovolemia (decreased blood plasma volume, also called "shock") that may occur as a result of serious injury, surgery, severe blood loss, burns, or other trauma.

Upload: rafael-paz

Post on 17-Aug-2015

214 views

Category:

Documents


2 download

TRANSCRIPT

Brand Name: Hextend GENERIC NAME: 6% Hetastarch in Lactated Electrolyte InectionMANUFACTURER: Biotime inc!DATE OF FDA APPROVAL: No"em#er $%&'DESCRIPTION: Hextend is a sterile medical I( sol)tion )sed as a #lood *lasma "ol)me ex*ander to re*lace #lood "ol)me lost in ro)tine s)r+ery, emer+ency tra)ma s)r+ery and other a**lications, a condition -no.n as hy*o"olemia /lo. #lood "ol)me0! Hextend1s )ni2)e 3orm)lation contains a modi3ied 3orm o3 starch /6% hetastarch0 s)s*ended in a #alanced electrolyte sol)tion! 4he *rod)ct more closely mirrors the electrolyte #alance o3 #lood than other *rod)cts that contain 6% hetastarch in sim*le salt /sodi)m chloride, or saline0 sol)tions! Hextend is not a s)#stit)te 3or #lood or *lasma!CLASSIFICATION: 5lasma ex*anderMECHANISM OF ACTION:4he #ody a)tomatically detects the lo.er haemo+lo#in le"el, and com*ensatory mechanisms start )*! 4he heart *)m*s more #lood .ith each #eat! 6ince the lost #lood .as re*laced .ith a s)ita#le 3l)id, the no. dil)ted #lood 3lo.s more easily, e"en in the small "essels! As a res)lt o3 chemical chan+es, more oxy+en is released to the tiss)es! 4hese ada*tations are so e33ecti"e that i3 only hal3 o3 the red #lood cells remain, oxy+en deli"ery may still #e a#o)t 78 *ercent o3 normal! A *atient at rest )ses only $8 *ercent o3 the oxy+en a"aila#le in his #lood! In extreme cases, *atients ha"es)r"i"ed .ith a haemo+lo#in le"el o3 $ +9dl, a#o)t &97 the norm, altho)+h le"els this lo. are "erydan+ero)s!INDICATION: Hetastarch is )sed to treat or *re"ent hy*o"olemia /decreased #lood *lasma "ol)me, also called :shoc-:0 that may occ)r as a res)lt o3 serio)s in)ry, s)r+ery, se"ere #lood loss, #)rns, or other tra)ma!SIDE EFFECTS: Consti*ation, na)sea, somnolence, 3ati+)e, headache, di;;iness, dry mo)th, "omitin+ , *r)rit)s, a#dominal *ain, edema *eri*heral, )**er res*iratory tract in3ection FOOD INTERACTION: !not indicatedSPECIAL INSTRUCTION:Hetastarch is inected into a "ein thro)+h an I(! A healthcare *ro"ider .ill +i"e yo) this inection!